No description available.

Os venenos de serpentes contêm concentrações elevadas de fosfolipases A2 secretadas (sFLA2), que apresentam homologia com as FLA2s de mamíferos, cujos níveis estão aumentados em doenças inflamatórias. Neste estudo, investigou-se a ativação e a expressão de fatores envolvidos na formação de corpúsculos lipídicos (CLs) em células fagociticas e o papel desses fatores na resposta imune inata, induzida pela MT-III, uma sFLA2s de veneno. A MT-III induziu aumento dos níveis de triacilglicerol, colesterol e lisofosfolipideos e a ativação e expressão dos fatores PPAR-g, PPAR-d/b, SREBP2 e do CD36. Sob estimulo da MT-III, o receptor PPAR-b/d, as enzimas DGAT, ACAT e FAS foram relevantes para a formação de CLs e para a expressão da PLIN2. O CD36 participa da expressão da COX-2, sem modificar a liberação de PGE2. O TLR2 e a MyD88 foram essenciais para a formação de CLs e síntese da IL-1b e IL-10. Ainda, o TLR2 foi relevante para a liberação de PGE2, PGD2 e LTB4, enquanto MyD88 foi fundamental somente para a liberação de PGE2 e expressão da PLIN2, induzidas pela MT-III. / Snake venoms contain high concentrations of secreted phospholipase A2 (sPLA2) with homology to mammalian PLA2s, whose levels are elevated in inflammatory diseases. In this study, we investigated activation and expression of factors involved in lipid droplets formation (LDs) and participation that factors in the innate immune response induced by MT-III, sPLA2s from snake venom, in phagocytic cells. MT-III induced increase of triacylglycerol, cholesterol and lysophospholipids levels and activation and expression of factors PPAR-g, PPAR-d/b, SREBP2 and CD36. PPAR-b/d receptor, DGAT, ACAT and FAS enzymes were relevant to LDs formation and critical to PLIN2 expression induced by MT-III. CD36 participates in COX-2 expression without modifying PGE2 release stimulated by MT-III. TLR2 and MyD88 were essential to LDs formation and IL-1b and IL-10 synthesis stimulated by MT-III. Moreover, TLR2 was relevant to PGE2, PGD2 and LTB4 biosynthesis, while MyD88 is essential only for PGE2 release and PLIN2 expression induced by MT-III.

Os venenos de serpentes contêm concentrações elevadas de fosfolipases A2 secretadas (sFLA2), que apresentam homologia com as FLA2s de mamíferos, cujos níveis estão aumentados em doenças inflamatórias. Neste estudo, investigou-se a ativação e a expressão de fatores envolvidos na formação de corpúsculos lipídicos (CLs) em células fagociticas e o papel desses fatores na resposta imune inata, induzida pela MT-III, uma sFLA2s de veneno. A MT-III induziu aumento dos níveis de triacilglicerol, colesterol e lisofosfolipideos e a ativação e expressão dos fatores PPAR-g, PPAR-d/b, SREBP2 e do CD36. Sob estimulo da MT-III, o receptor PPAR-b/d, as enzimas DGAT, ACAT e FAS foram relevantes para a formação de CLs e para a expressão da PLIN2. O CD36 participa da expressão da COX-2, sem modificar a liberação de PGE2. O TLR2 e a MyD88 foram essenciais para a formação de CLs e síntese da IL-1b e IL-10. Ainda, o TLR2 foi relevante para a liberação de PGE2, PGD2 e LTB4, enquanto MyD88 foi fundamental somente para a liberação de PGE2 e expressão da PLIN2, induzidas pela MT-III. / Snake venoms contain high concentrations of secreted phospholipase A2 (sPLA2) with homology to mammalian PLA2s, whose levels are elevated in inflammatory diseases. In this study, we investigated activation and expression of factors involved in lipid droplets formation (LDs) and participation that factors in the innate immune response induced by MT-III, sPLA2s from snake venom, in phagocytic cells. MT-III induced increase of triacylglycerol, cholesterol and lysophospholipids levels and activation and expression of factors PPAR-g, PPAR-d/b, SREBP2 and CD36. PPAR-b/d receptor, DGAT, ACAT and FAS enzymes were relevant to LDs formation and critical to PLIN2 expression induced by MT-III. CD36 participates in COX-2 expression without modifying PGE2 release stimulated by MT-III. TLR2 and MyD88 were essential to LDs formation and IL-1b and IL-10 synthesis stimulated by MT-III. Moreover, TLR2 was relevant to PGE2, PGD2 and LTB4 biosynthesis, while MyD88 is essential only for PGE2 release and PLIN2 expression induced by MT-III.

Submitted by Renata Lopes (renatasil82@gmail.com) on 2018-03-27T15:52:21Z No. of bitstreams: 1 analuizadasilvaalbertoni.pdf: 1260028 bytes, checksum: cc0af4aab8dc00d61833430e0eb2ce88 (MD5) / Approved for entry into archive by Adriana Oliveira (adriana.oliveira@ufjf.edu.br) on 2018-04-09T19:21:51Z (GMT) No. of bitstreams: 1 analuizadasilvaalbertoni.pdf: 1260028 bytes, checksum: cc0af4aab8dc00d61833430e0eb2ce88 (MD5) / Made available in DSpace on 2018-04-09T19:21:51Z (GMT). No. of bitstreams: 1 analuizadasilvaalbertoni.pdf: 1260028 bytes, checksum: cc0af4aab8dc00d61833430e0eb2ce88 (MD5) Previous issue date: 2017-08-14 / CAPES - Coordenação de Aperfeiçoamento de Pessoal de Nível Superior / CNPq - Conselho Nacional de Desenvolvimento Científico e Tecnológico / FAPEMIG - Fundação de Amparo à Pesquisa do Estado de Minas Gerais / A obesidade é uma doença crônica multifatorial caracterizada pelo excesso de gordura corporal e por um estado inflamatório de baixo grau, conhecido como metainflamação. Atualmente, é um dos principais problemas de saúde pública do mundo. Dados da OMS indicam que 13% da população mundial é obesa e no Brasil, o índice subiu para 17,9% da população em 2014. Fatores genéticos, dieta, desordens metabólicas, como intolerância à glicose, dislipidemias, hipertensão arterial sistêmica, desbalanço hormonal e mudanças na microbiota intestinal, são gatilhos da inflamação envolvendo adipócitos. O tecido adiposo obeso é caracterizado pelo aumento da infiltração de macrófagos, sendo estes uma fonte importante de inflamação neste tecido. Fatores transcricionais com propriedades imunorregulatórias estão envolvidos em processos inflamatórios e na adipogênese. PPARγ é um importante receptor ativado por ligantes lipídicos, regulador central da adipogênese, com funções na ativação de células do sistema imune e no metabolismo lipídico. Dados de nosso grupo demonstraram que ativação de PPARγ induz a biogênese de organelas dinâmicas denominadas Corpúsculos Lipídicos (CLs) durante infeção micobacteriana. Estas organelas possuem funções ativas no estoque de lipídios para geração de energia, síntese de membrana, síntese de mediadores inflamatórios, sinalização celular e inflamação. Além disso, os CL em macrófagos funcionam como sítios para sobrevivência de patógenos, como as micobactérias. Apesar do impacto da obesidade em doenças metabólicas e cardiovasculares ser bem compreendido, os mecanismos envolvidos na relação entre adipócitos e macrófagos infectados com patógenos intracelulares não são conhecidos, sendo este esclarecimento o objetivo de nosso estudo. Para isso, diferencianciamos células NIH3T3-L1 em adipócitos e utilizamos o sobrenadante obtido, para estimular macrófagos peritoneais infectados ou não com M. bovis BCG. Nós avaliamos a biogênese de corpúsculos lipídicos, expressão de PPARγ, síntese e secreção de citocinas, adipocinas e NO. Os resultados comprovaram que a diferenciação de células NIH3T3-L1 em adipócitos é um processo eficiente que envolve mudanças na morfologia celular e acúmulo de Corpúsculos Lipídicos. O estímulo de macrófagos com sobrenadante de adipócitos potencializou a biogênese de CLs, assim como a expressão de PPARγ, na presença de infecção micobacteriana. Nos tempos de 6 e 48 horas de estímulo com sobrenadante e infecção, a produção de TNF-α também foi potencializada, porém um decréscimo significativo foi observado no tempo de 24 horas. Quanto aos níveis de IL-10, um aumento foi observado na presença de infecção e estímulo com sobrenadante nos três tempos analisados. Além disso, apenas no tempo de 24 h observamos a secreção de nitrito de modo significativo pelos macrófagos peritoneais infectados, efeito este independente do estímulo com sobrenadante. Quanto às adipocinas, importantes no desenvolvimento da obesidade e síndrome metabólica, analisamos os níveis de leptina produzida pelos macrófagos que não foram significativos, enquanto a produção de adiponectina, apresentou-se aumentada nos macrófagos controles estimulados com sobrenadante, efeito este, que foi inibido durante a infecção por BCG. Assim, nossos resultados sugerem, um efeito modulador de fatores secretados por adipócitos na ativação de macrófagos, atribuídos a formação de corpúsculos lipídicos, expressão de PPARγ, síntese de citocinas como TNF-α e IL-10 e uma modulação negativa da produção de adiponectina durante a infecção por M. bovis BCG. / Obesity is a chronic multifactorial disease characterized by excess of body fat and a low- grade inflammatory state, known as meta-inflammation. It is currently one of the world's leading public health problems. WHO data indicate that 13% of the world population is obese, in Brazil, the obesity index was 17.9% of the population in 2014. In addition to genetic factors, diet and metabolic disorders, such as glucose intolerance, dyslipidemia, systemic arterial hypertension, hormonal imbalance and changes in the intestinal microbiota have been proposed as triggers for inflammation involving adipocytes. Recent studies have shown that obese adipose tissue is characterized by increased infiltration of macrophages, suggesting that these are an important source of inflammation in this tissue. Transcriptional factors with immunoregulatory properties are involved in inflammatory processes and adipogenesis. Such as the PPARγ, is a receptor activated by lipid ligands, central regulator of adipogenesis, with functions in the immune cells activation and lipid metabolism. Data from our group, demonstrated that PPARγ activation induces the biogenesis of dynamic organelles, the Lipid Droplets (LD) during mycobacterial infection. These organelles have functions in lipid storage for energy generation, membrane synthesis, inflammatory mediators synthesis, cell signaling and inflammation. Moreover, the LD in macrophages are niches for the pathogens survival. Although the impact of obesity on metabolic and cardiovascular diseases is understood, the mechanisms involved in the interactions between adipocytes and macrophages infected with intracellular pathogens are not known. In this study we differentiated NIH3T3-L1 cells into adipocytes and used the supernatant obtained to stimulate peritoneal macrophages infected or not with M. bovis BCG. We analyze the lipids droplets formation, PPARγ expression, cytokine, adipokines and NO synthesis. The results have shown that NIH3T3-L1 cells differentiation into adipocytes is an efficient process involving changes in cell morphology and LD storage. The macrophages stimulation with adipocyte supernatant was able to potentiated LD biogenesis, as well as, PPARγ activation, during mycobacterial infection. After 6 and 48 hours of stimulation and infection, the TNF-α levels were also potentiated, although a significant decrease was observed after 24 hours of infection. The IL-10 levels, was increase in the presence of infection and supernatant stimulation at 6, 24 and 48 hours after infection. To nitrite analysis, we observe that after 24 h of infection, there was an increase of levels secreted by macrophages, however this effect was independent of the supernatant stimulation. The adipokines, as leptin and adiponectin, are important factors in the obesity and metabolic syndrome development. Therefore, we analyzed the levels of leptin and adiponectin produced by macrophages during BCG infection. The Leptin levels were not detect, while adiponectin production, was increased in the control macrophages in presence of supernatant, an effect that was inhibited during BCG infection. Thus, our results suggest a modulating effect of secreted factors by adipocytes on the macrophages activation, attributed to the lipid droplets formation, PPARγ expression, cytokines synthesis as TNF-α and IL-10 and a dowmodulation of adiponectin during M. bovis BCG, infection.

Les septines sont une famille de protéines GTPases qui peuvent former des structures d'ordre supérieur, comme les filaments et les anneaux, et capables de se lier avec les membranes cellulaires par leur interaction avec les phosphoinositides (PIs) via un domaine polybasique en N-terminal de leur domaine de liaison au GTP. Nous avons montré par une analyse transcriptomique réalisée en utilisant les données GSE14323 que la septine 9 est significativement surexprimée dans la cirrhose induite par le virus de l'hepatite C (VHC). Nos résultats montrent, ainsi, que la septine 9 induit l’augmentation en taille des gouttelettes lipidiques (GLs) par un mécanisme dépendant le phosphatidylinositol-5-phosphate et des microtubules. Nous avons montré, également, que cette voie de régulation des GLs est exploité par le VHC. De plus, nous avons montré que la septine 9 est impliquée dans la régulation de la morphologie de l’appareil Golgi et la mise en place de la polarité cellulaire par son interaction avec les phosphoinositides via deux domaines polybasiques. Ces résultats apportent une nouvelle compréhension du mécanisme moléculaire de l’interaction des septines avec les phosphoinositides et montrent pour la première fois l’importance de cette interaction dans des fonctions cellulaires de la septine 9. / Septins are a GTPases proteins family that can form high order structures such as filaments and rings, and able to bind cell membranes by interacting with phosphoinositides via a polybasic domain located at the N-terminal of their GTP binding domain. Here, We show by the transcriptomic analysis performed using the GSE14323 dataset that septin 9 is significantly upregulated in hepatitis C virus induced cirrhosis. Our findings show that septin 9 induce the lipid droplet growth by a phosphatidylinositol-5-phosphate and microtubule-dependent mechanism hijacked by HCV. In addition, we have shown that the septin 9 is involved in Golgi apparatus morphology regulation and cell polarity installation by interacting with phosphoinositides via two polybasic domains. These results provide new understanding of the molecular mechanism of septins interaction with the phosphoinositides and show its importance in septin 9 cellular functions shown for the first time.

Metabolic energy is most efficiently stored as triacylglycerol (TAG). This neutral lipid accumulates mainly within adipose tissues, but it can be stored and used in all types of cells. Within cells it is packed in organelles called lipid droplets (LDs). They consist of a core of neutral lipids like TAG and cholesterol esters, which is surrounded by a phospholipid monolayer that mainly consists of phosphatidylcholine (PC). Attached to or inserted into this monolayer are various proteins, mainly LD specific structural proteins or lipid metabolic enzymes. Though excess uptake of nutrition leads to lipid accumulation in all kinds of body tissues, which is accompanied by the augmentation of LDs and results in cellular dysfunction and the development of metabolic diseases, relatively little is known about the biogenesis and growth of LDs. This thesis focuses on diacylglycerol acyltransferase 2 (DGAT2), an enzyme of the TAG biosynthetic pathway, and on lyso-phosphatidylcholine acyltransferases 1 and 2 (LPCAT1 and LPCAT2), both enzymes of one of the PC biosynthetic pathways called Lands cycle. The data presented in this thesis show that these enzymes can localize to LDs and that they actively synthesize TAG and PC at the surface of LDs. While the LPCATs reside on LDs independent from the nutrition status of the cell, DGAT2 accumulates on LDs upon excess availability of oleic acid. DGAT2, LPCAT1 and LPCAT2 differ in their structure from other iso-enzymes that catalyze the same reactions. This thesis shows that they exhibit a monotopic conformation and that they contain a hydrophobic stretch that presumably forms a hairpin. This topology enables them to localize to both a phospholipid bilayer like the membrane of the endoplasmic reticulum and to a phospholipid monolayer like the surface of LDs. The different biophysical properties of the structures of iso-enzymes might be responsible for their subcellular localization and the formation of distinct TAG or PC pools that are destined for different purposes. This would explain, why the iso-enzymes are often not able to replace each other. Knock-down and overexpression experiments performed in this thesis show that the activity of LPCAT1, LPCAT2 and DGAT2 influence the packaging of lipids within LDs. Knock-down of LPCAT1 and LPCAT2 leads to an increase in LD size without concomitant increase in the amount of TAG. Combined with the finding that the profile of the PC species of the LD surface reflects the substrate preferences of LPCAT1 and LPCAT2, the results suggest that these enzymes are responsible for the formation of the LD surface. Therefore, the increase in LD size upon LPCAT1 and LPCAT2 knock-down results from an adjustment of the surface-to-volume ratio in response to reduced availability of surface lipids. The connection between LPCATs and LD size was corroborated in the model organism Drosophila melanogaster. Three different knockout fly strains of the Drosophila homologue of LPCAT1 and LPCAT2, CG32699, exhibit enlarged LDs in the fat body of the L3 larvae. Furthermore, the data presented suggest that the morphology of LDs is important for the secretion of stored lipids. The reduction of LPCAT1 in liver cells leads to a reduction in lipoprotein particle release. This was shown by measuring the amount of released apolipoproteinB with two different methods, by measuring the release of lipids and by quantification of the amount of released hepatitis C virus, which is known to rely on LD interaction for replication and on lipoprotein particles for cellular release. DGAT2 is recruited to LDs upon excess availability of oleic acid and its overexpression leads to the formation of many, but relatively small LDs. Here, it is shown that DGAT2 interacts with acyl-CoA synthetase ligase 1 (ACSL1), an enzyme that catalyzes the activation of free fatty acids with Coenzyme A. This interaction does not influence the stability of DGAT2 nor does it seem to affect lipid synthesis. Nevertheless, it shows an influence on lipid packaging in LDs. While overexpression of DGAT2 results in the appearance of smaller LDs, overexpression of ACSL1 leads to an increase in LD size. Coexpression of ACSL1 and DGAT2 reverses the phenotypes obtained by single overexpression and normalizes the mean LD diameter to values observed at normal conditions. In conclusion, this thesis shows that LDs are able to synthesize the components of their core and their surface, which underlines their independent function in metabolism. Additionally, the results show that LDs can grow by local synthesis and that the responsible enzymes exhibit a monotopic membrane topology, which might be crucial for LD localization. Furthermore, the obtained data suggest that the localization and the ratio between different enzyme activities influence the packaging of lipids and affects lipid secretion and therefore impact the whole body lipid metabolism.

No description available.

Targeting molecular alterations as an effective treatment for isocitrate dehydrogenasewildtype glioblastoma (GBM) patients has not yet been established. Sterol-O-Acyl Transferase 1 (SOAT1), a key enzyme in the conversion of endoplasmic reticulum cholesterol to esters for storage in lipid droplets (LD), serves as a target for the orphan drug mitotane to treat adrenocortical carcinoma. Inhibition of SOAT1 also suppresses GBM growth. Here, we refined SOAT1-expression in GBM and IDH-mutant astrocytoma, CNS WHO grade 4 (HGA), and assessed the distribution of LD in these tumors. Twenty-seven GBM and three HGA specimens were evaluated by multiple GFAP, Iba1, IDH1 R132H, and SOAT1 immunofluorescence labeling as well as Oil Red O staining. To a small extent SOAT1 was expressed by tumor cells in both tumor entities. In contrast, strong expression was observed in glioma-associated macrophages. Triple immunofluorescence labeling revealed, for the first time, evidence for SOAT1 colocalization with Iba1 and IDH1 R132H, respectively. Furthermore, a notable difference in the amount of LD between GBM and HGA was observed. Therefore, SOAT1 suppression might be a therapeutic option to target GBM and HGA growth and invasiveness. In addition, the high expression in cells related to neuroinflammation could be beneficial for a concomitant suppression of protumoral microglia/macrophages.

<p dir="ltr">Immunotherapy has revolutionized the field of oncology. While a lot of antibodies and small molecule inhibitors have been developed for this, a lot of targets remain undruggable in humans.</p><p dir="ltr">Targeted protein degradation has opened a new horizon in drug discovery where we can target these undruggable proteins. Proteolysis targeting chimeras using the ubiquitin-proteasomal system is one of the most popular TPD strategies that complement lysosomal degradation strategies to degrade intracellular proteins, typically using bifunctional small molecule degraders. Recently, large biomolecular and antibody conjugates have been developed for degrading membrane and extracellular proteins in cells, such as lysosomal targeting chimeras (LYTACs) and genetically encoded LYTACS, among several others. However, larger molecules have limitations in penetrating solid tumors. This dissertation work focused on the development of bifunctional small molecule degraders for programmed death-ligand 1 (PD-L1), a transmembrane protein ligand for the immune checkpoint programmed cell death 1 (PD-1). PD-L1 is highly expressed on several tumors, such as triple-negative breast cancer (TNBC), non-small cell lung carcinoma, and renal cancer, and is known to suppress cancer-killing immune cells via interaction with PD-1 on T-cells. In addition, PD-L1 is also present on macrophages in the tumor microenvironments leading to further immune suppression and acquired resistance to anti-PD-1 therapy is associated with the upregulation of alternative immune checkpoints, thereby reducing anti-tumor efficacy. We have designed and synthesized bifunctional small molecules as PD-L1 degraders with different recruiters and linkers guided by computational studies with known PD-1/PD-L1 structures to show both cell surface and total protein degradation in human TNBC cells. In a separate project, we also developed small molecule conjugates to degrade an intracellular integral membrane protein of the endoplasmic reticulum with an unknown 3D structure, namely Diglyceride acyltransferase 2 (DGAT2). Recently, our lab identified DGAT2 as a new target for combating Alzheimer’s disease. Specifically, DGAT2 catalyzes triacylglycerol (TAG) synthesis using diacylglycerol and fatty acyl CoA as substrates. The accumulation of TAGs, mechanistically linked to DGAT2, results in “fat” or lipid droplets (LDs) inside the cells. Our lab showed that microglial cells (resident immune cells in the brain) accumulate LDs in the postmortem brains of human patients and mouse models (5xFAD) of Alzheimer’s disease and that the LD accumulation is driven by amyloid-beta (Ab) – a hallmark of Alzheimer’s disease – via DGAT2 pathway. Further, these LD-laden microglia have phagocytic defects and are spared Aβ thereby affecting plaque accumulation and clearance. Inhibiting DGAT2 reduces the amount of TAG in the brain, which in turn reduces LDs and restores microglial ability to phagocytose Ab. However, commercially available DGAT2 inhibitors were unable to reduce LD load in older 5xFAD mice. Using AlphaFold’s models of DGAT2, we designed and identified sites to synthesize bifunctional DGAT2 degraders that resulted in reduced LDs in mouse primary microglial cells and enhanced phagocytosis of Aβ plaques in vivo in aged 5xFAD mice. Our approach shows a framework to develop bifunctional small molecule degraders for membrane proteins to potentially combat immune dysregulation in chronic diseases.</p>

Le VHC infecte les hépatocytes, cellules polarisées du foie. Le cycle de réplication du VHC est dépendant du métabolisme lipidique de la cellule hôte. Mais la relation entre VHC, polarité cellulaire et métabolisme lipidique est mal connue. Nous avons démontré que SHIP2 joue un rȏle important dans l’établissement de la polarité apicobasale des cellules épithéliales. La protéine core du HCV induit la perte de polarité cellulaire et diminue l’expression de la phosphatase SHIP2. La réintroduction de SHIP2 dans les cellules exprimant core restitue la polarité cellulaire et diminue l’expression de core. SHIP2 agit aussi sur l’accumulation et l’organisation des gouttelettes lipidiques qui sont des éléments cellulaires nécessaires à la réplication du VHC. Ces résultats montrent le rôle de SHIP2 dans la polarité cellulaire et le désigne comme une cible intéressante pour des recherches dans la lutte contre les infections du VHC. / HCV infects hepatocytes, polarized cells of the liver. HCV replication cycle is dependent on lipid metabolism of the host cell. But the relationship between HCV cell polarity and lipid metabolism is unknown. We demonstrated that SHIP2 plays an important role in establishment of the apicobasal epithelial cell polarity. The HCV core protein induces loss of cell polarity and decreases the expression of the phosphatase SHIP2. The reintroduction of SHIP2 in cells expressing core restores cell polarity and decreases the expression of core protein. SHIP2 also negatively affect lipid droplets, which are important for HCV replication. These results show the role of SHIP2 in cell polarity and designate it as an attractive target for research in the fight against HCV infection.